Fig. 1From: Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?Kaplan–Meier survival curves comparing 3-year (a) recurrence-free survival (RFS) and (b) overall survival (OS) rates, based on administration of adjuvant chemotherapy (ACT) in patients who develop colorectal oligometastases to liver after curative liver resectionBack to article page